Glucagon-like peptide 2, a product of glucagon gene expression, and analogs
of glucagon-like peptide 2, have been identified as gastrointestinal
tissue growth factors. Their effects on the growth of small bowel and
pancreatic islets are described. Their formulation as a pharmaceutical,
and their therapeutic use in treating disorders of the bowel, are
described.
